Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Gastrointestinal Polyposis in Pediatric Patients.

MacFarland SP, Zelley K, Katona BW, Wilkins BJ, Brodeur GM, Mamula P.

J Pediatr Gastroenterol Nutr. 2019 Jun 17. doi: 10.1097/MPG.0000000000002421. [Epub ahead of print]

PMID:
31211762
2.

Efficacy of Epicutaneous Immunotherapy in Children with Milk-Induced Eosinophilic Esophagitis.

Spergel JM, Elci OU, Muir AB, Liacouras CA, Wilkins BJ, Burke D, Lewis MO, Brown-Whitehorn T, Cianferoni A.

Clin Gastroenterol Hepatol. 2019 May 14. pii: S1542-3565(19)30524-5. doi: 10.1016/j.cgh.2019.05.014. [Epub ahead of print]

PMID:
31100455
3.

Posttranscriptional regulation of colonic epithelial repair by RNA binding protein IMP1/IGF2BP1.

Chatterji P, Williams PA, Whelan KA, Samper FC, Andres SF, Simon LA, Parham LR, Mizuno R, Lundsmith ET, Lee DS, Liang S, Wijeratne HS, Marti S, Chau L, Giroux V, Wilkins BJ, Wu GD, Shah P, Tartaglia GG, Hamilton KE.

EMBO Rep. 2019 Jun;20(6). pii: e47074. doi: 10.15252/embr.201847074. Epub 2019 May 6.

PMID:
31061170
4.

Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience.

Kennedy K, Muir AB, Grossman A, Brown-Whitehorn T, Cianferoni A, Spergel JM, Furuta GT, Wilkins BJ, Shuker M, Ruffner MA.

J Allergy Clin Immunol Pract. 2019 Feb 11. pii: S2213-2198(19)30162-X. doi: 10.1016/j.jaip.2019.01.053. [Epub ahead of print] No abstract available.

PMID:
30763733
5.

Single-nucleus transcriptomic survey of cell diversity and functional maturation in postnatal mammalian hearts.

Hu P, Liu J, Zhao J, Wilkins BJ, Lupino K, Wu H, Pei L.

Genes Dev. 2018 Oct 1;32(19-20):1344-1357. doi: 10.1101/gad.316802.118. Epub 2018 Sep 25.

6.

Loss of HDAC6 alters gut microbiota and worsens obesity.

Lieber AD, Beier UH, Xiao H, Wilkins BJ, Jiao J, Li XS, Schugar RC, Strauch CM, Wang Z, Brown JM, Hazen SL, Bokulich NA, Ruggles KV, Akimova T, Hancock WW, Blaser MJ.

FASEB J. 2019 Jan;33(1):1098-1109. doi: 10.1096/fj.201701586R. Epub 2018 Aug 13.

PMID:
30102568
7.

Lipid malabsorption from altered hormonal signaling changes early gut microbial responses.

Terry NA, Ngaba LV, Wilkins BJ, Pi D, Gheewala N, Kaestner KH.

Am J Physiol Gastrointest Liver Physiol. 2018 Oct 1;315(4):G580-G591. doi: 10.1152/ajpgi.00135.2018. Epub 2018 Jun 28.

PMID:
29953253
8.

Genomic integration of ERRγ-HNF1β regulates renal bioenergetics and prevents chronic kidney disease.

Zhao J, Lupino K, Wilkins BJ, Qiu C, Liu J, Omura Y, Allred AL, McDonald C, Susztak K, Barish GD, Pei L.

Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4910-E4919. doi: 10.1073/pnas.1804965115. Epub 2018 May 7.

9.

GDF15 is a heart-derived hormone that regulates body growth.

Wang T, Liu J, McDonald C, Lupino K, Zhai X, Wilkins BJ, Hakonarson H, Pei L.

EMBO Mol Med. 2017 Aug;9(8):1150-1164. doi: 10.15252/emmm.201707604.

10.

Influence of Age and Eosinophilic Esophagitis on Esophageal Distensibility in a Pediatric Cohort.

Menard-Katcher C, Benitez AJ, Pan Z, Ahmed FN, Wilkins BJ, Capocelli KE, Liacouras CA, Verma R, Spergel JM, Furuta GT, Muir AB.

Am J Gastroenterol. 2017 Sep;112(9):1466-1473. doi: 10.1038/ajg.2017.131. Epub 2017 May 16.

11.

Glutathione antioxidant pathway activity and reserve determine toxicity and specificity of the biliary toxin biliatresone in zebrafish.

Zhao X, Lorent K, Wilkins BJ, Marchione DM, Gillespie K, Waisbourd-Zinman O, So J, Koo KA, Shin D, Porter JR, Wells RG, Blair I, Pack M.

Hepatology. 2016 Sep;64(3):894-907. doi: 10.1002/hep.28603. Epub 2016 Jun 11.

12.

Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE).

Chandramouleeswaran PM, Shen D, Lee AJ, Benitez A, Dods K, Gambanga F, Wilkins BJ, Merves J, Noah Y, Toltzis S, Yearley JH, Spergel JM, Nakagawa H, Malefyt Rd, Muir AB, Wang ML.

PLoS One. 2016 Mar 18;11(3):e0150968. doi: 10.1371/journal.pone.0150968. eCollection 2016.

13.

Axial contraction and short-range compaction of chromatin synergistically promote mitotic chromosome condensation.

Kruitwagen T, Denoth-Lippuner A, Wilkins BJ, Neumann H, Barral Y.

Elife. 2015 Nov 28;4:e1039. doi: 10.7554/eLife.10396.

14.

Engineering the gut microbiota to treat hyperammonemia.

Shen TC, Albenberg L, Bittinger K, Chehoud C, Chen YY, Judge CA, Chau L, Ni J, Sheng M, Lin A, Wilkins BJ, Buza EL, Lewis JD, Daikhin Y, Nissim I, Yudkoff M, Bushman FD, Wu GD.

J Clin Invest. 2015 Jul 1;125(7):2841-50. doi: 10.1172/JCI79214. Epub 2015 Jun 22.

15.

Genetically encoding lysine modifications on histone H4.

Wilkins BJ, Hahn LE, Heitmüller S, Frauendorf H, Valerius O, Braus GH, Neumann H.

ACS Chem Biol. 2015 Apr 17;10(4):939-44. doi: 10.1021/cb501011v. Epub 2015 Jan 20.

PMID:
25590375
16.

Left knee pain and bilateral knee swelling in an adolescent.

Mistovich RJ, O'Toole PO, Chauvin NA, Wilkins BJ, Ganley TJ.

Clin Orthop Relat Res. 2014 Nov;472(11):3591-8. doi: 10.1007/s11999-014-3883-4. Epub 2014 Aug 28. No abstract available.

17.
18.

A cascade of histone modifications induces chromatin condensation in mitosis.

Wilkins BJ, Rall NA, Ostwal Y, Kruitwagen T, Hiragami-Hamada K, Winkler M, Barral Y, Fischle W, Neumann H.

Science. 2014 Jan 3;343(6166):77-80. doi: 10.1126/science.1244508.

PMID:
24385627
19.

p53-mediated biliary defects caused by knockdown of cirh1a, the zebrafish homolog of the gene responsible for North American Indian Childhood Cirrhosis.

Wilkins BJ, Lorent K, Matthews RP, Pack M.

PLoS One. 2013 Oct 11;8(10):e77670. doi: 10.1371/journal.pone.0077670. eCollection 2013.

20.

Zebrafish models of human liver development and disease.

Wilkins BJ, Pack M.

Compr Physiol. 2013 Jul;3(3):1213-30. doi: 10.1002/cphy.c120021. Review.

21.

Condensed E. coli cultures for highly efficient production of proteins containing unnatural amino acids.

Liu J, Castañeda CA, Wilkins BJ, Fushman D, Cropp TA.

Bioorg Med Chem Lett. 2010 Oct 1;20(19):5613-6. doi: 10.1016/j.bmcl.2010.08.049. Epub 2010 Aug 13.

22.

Site-specific incorporation of fluorotyrosines into proteins in Escherichia coli by photochemical disguise.

Wilkins BJ, Marionni S, Young DD, Liu J, Wang Y, Di Salvo ML, Deiters A, Cropp TA.

Biochemistry. 2010 Mar 2;49(8):1557-9. doi: 10.1021/bi100013s.

PMID:
20136096
23.

Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery.

Wilkins BJ, Lewis JS Jr.

Head Neck Pathol. 2009 Jun;3(2):140-9. doi: 10.1007/s12105-009-0115-4. Epub 2009 Apr 28. Review.

24.

Photochemical control of FlAsH labeling of proteins.

Wilkins BJ, Yang X, Cropp TA.

Bioorg Med Chem Lett. 2009 Aug 1;19(15):4296-8. doi: 10.1016/j.bmcl.2009.05.072. Epub 2009 May 27.

PMID:
19500980
25.

Peptide mass fingerprinting using isotopically encoded photo-crosslinking amino acids.

Wilkins BJ, Daggett KA, Cropp TA.

Mol Biosyst. 2008 Sep;4(9):934-6. doi: 10.1039/b801512k. Epub 2008 Jul 17.

PMID:
18704231
26.

Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.

Purcell NH, Wilkins BJ, York A, Saba-El-Leil MK, Meloche S, Robbins J, Molkentin JD.

Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14074-9. Epub 2007 Aug 20.

27.

Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth.

Liu Q, Wilkins BJ, Lee YJ, Ichijo H, Molkentin JD.

Mol Cell Biol. 2006 May;26(10):3785-97.

29.

Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.

Wilkins BJ, Molkentin JD.

Biochem Biophys Res Commun. 2004 Oct 1;322(4):1178-91. Review.

PMID:
15336966
30.

MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo.

Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, Voisin L, Saba-El-Leil MK, Meloche S, Pouysségur J, Pagès G, De Windt LJ, Doevendans PA, Molkentin JD.

Circulation. 2004 Apr 27;109(16):1938-41. Epub 2004 Apr 19.

PMID:
15096454
31.

Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy.

Parsons SA, Millay DP, Wilkins BJ, Bueno OF, Tsika GL, Neilson JR, Liberatore CM, Yutzey KE, Crabtree GR, Tsika RW, Molkentin JD.

J Biol Chem. 2004 Jun 18;279(25):26192-200. Epub 2004 Apr 13.

32.

The DNA damage checkpoint and PKA pathways converge on APC substrates and Cdc20 to regulate mitotic progression.

Searle JS, Schollaert KL, Wilkins BJ, Sanchez Y.

Nat Cell Biol. 2004 Feb;6(2):138-45. Epub 2004 Jan 25.

PMID:
14743219
33.

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD.

Circ Res. 2004 Jan 9;94(1):110-8. Epub 2003 Dec 1.

PMID:
14656927
34.

Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction.

Bueno OF, Lips DJ, Kaiser RA, Wilkins BJ, Dai YS, Glascock BJ, Klevitsky R, Hewett TE, Kimball TR, Aronow BJ, Doevendans PA, Molkentin JD.

Circ Res. 2004 Jan 9;94(1):91-9. Epub 2003 Nov 13.

PMID:
14615291
35.

c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.

Liang Q, Bueno OF, Wilkins BJ, Kuan CY, Xia Y, Molkentin JD.

EMBO J. 2003 Oct 1;22(19):5079-89.

36.

Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted mice.

Parsons SA, Wilkins BJ, Bueno OF, Molkentin JD.

Mol Cell Biol. 2003 Jun;23(12):4331-43.

37.

Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE, Molkentin JD.

J Clin Invest. 2003 May;111(10):1475-86.

38.

Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth.

Wilkins BJ, De Windt LJ, Bueno OF, Braz JC, Glascock BJ, Kimball TF, Molkentin JD.

Mol Cell Biol. 2002 Nov;22(21):7603-13.

39.

Calcineurin and cardiac hypertrophy: where have we been? Where are we going?

Wilkins BJ, Molkentin JD.

J Physiol. 2002 May 15;541(Pt 1):1-8. Review.

40.

Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice.

Bueno OF, Wilkins BJ, Tymitz KM, Glascock BJ, Kimball TF, Lorenz JN, Molkentin JD.

Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4586-91. Epub 2002 Mar 19.

41.

Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia.

Lee DW, Zhang K, Ning ZQ, Raabe EH, Tintner S, Wieland R, Wilkins BJ, Kim JM, Blough RI, Arceci RJ.

Cancer Res. 2000 Jul 1;60(13):3612-22.

42.

Unsaturated steroids. Part 3. Synthesis of steroidal 22,24(28)-dienes, erogosta-5,7,22,24(28)-tetraen-3beta-ol, and cholesta-5,7,22-trien-3beta-ol.

Garry AB, Midgley JM, Whalley WB, Wilkins BJ.

J Chem Soc Perkin 1. 1977;(8):809-12. No abstract available.

PMID:
558995
43.

Metabolism of nealbarbitone.

Gilbert JN, Millard BJ, Powell JW, Whalley WB, Wilkins BJ.

J Pharm Pharmacol. 1974 Feb;26(2):119-22. No abstract available.

PMID:
4150827

Supplemental Content

Loading ...
Support Center